Insider trading

Period: 120 months Stock: GOSS Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

40 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

40 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

40 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

40 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
40 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
40 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

40 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Jun 2024
Aranda Richard Chief Medical Officer
Sold at will
$1.26K 1,908 at 0.66
1.0%
Not planned
27 Mar 2024
Hasnain Faheem President & CEO
Sold at will
$26.77K 23,172 at 1.16
16.2%
Not planned
27 Mar 2024
Giraudo Bryan COO/CFO
Sold at will
$7.43K 6,430 at 1.16
6.5%
Not planned
27 Mar 2024
Christian Waage EVP, Tech Ops and Admin
Sold at will
$7.43K 6,430 at 1.16
1.1%
Not planned
18 Mar 2024
Peterson Caryn EVP, Regulatory Affairs
Sold at will
$5.34K 4,018 at 1.33
7.5%
Not planned
18 Mar 2024
Aranda Richard Chief Medical Officer
Sold at will
$5.34K 4,018 at 1.33
2.0%
Not planned
22 Jun 2023
Aranda Richard Chief Medical Officer
Sold at will
$2.34K 1,814 at 1.29
0.9%
Not planned
16 Mar 2023
Peterson Caryn EVP, Regulatory Affairs
Sold at will
$8.31K 7,564 at 1.10
12.3%
Not planned
16 Mar 2023
Aranda Richard Chief Medical Officer
Sold at will
$8.30K 7,563 at 1.10
3.7%
Not planned
16 Mar 2023
Carter Laura Chief Scientific Officer
Sold at will
$6.62K 6,029 at 1.10
7.3%
Not planned
24 Oct 2022
Carter Laura Chief Scientific Officer
Sold, plan not stated
$58.87K 4,876 at 12.07
5.6%
24 Oct 2022
Aranda Richard Chief Medical Officer
Sold, plan not stated
$57.43K 4,757 at 12.07
2.3%
24 Oct 2022
Peterson Caryn EVP, Regulatory Affairs
Sold, plan not stated
$57.43K 4,757 at 12.07
7.2%
1 Jul 2022
Carter Laura Chief Scientific Officer
Sold, plan not stated
$72.65K 8,808 at 8.25
9.9%
22 Jun 2022
Aranda Richard Chief Medical Officer
Sold, plan not stated
$12.23K 1,778 at 6.88
0.8%
4 May 2022
Carter Laura Chief Scientific Officer
Sold, plan not stated
$9.09K 1,262 at 7.20
1.4%
23 Mar 2022
Hasnain Faheem President & CEO
Sold, plan not stated
$169.70K 19,035 at 8.92
11.7%
23 Mar 2022
Giraudo Bryan COO/CFO
Sold, plan not stated
$95.59K 10,722 at 8.92
9.8%
23 Mar 2022
Christian Waage EVP, Tech Ops and Admin
Sold, plan not stated
$95.59K 10,722 at 8.92
1.8%
16 Mar 2022
Peterson Caryn EVP, Regulatory Affairs
Sold, plan not stated
$51.98K 6,279 at 8.28
8.7%
16 Mar 2022
Aranda Richard Chief Medical Officer
Sold, plan not stated
$51.98K 6,278 at 8.28
2.9%
16 Mar 2022
Carter Laura Chief Scientific Officer
Sold, plan not stated
$41.41K 5,002 at 8.28
5.2%
25 Oct 2021
Aranda Richard Chief Medical Officer
Sold, plan not stated
$29.12K 2,377 at 12.25
1.1%
25 Oct 2021
Carter Laura Chief Scientific Officer
Sold, plan not stated
$29.12K 2,377 at 12.25
2.4%
25 Oct 2021
Peterson Caryn EVP, Regulatory Affairs
Sold, plan not stated
$29.12K 2,377 at 12.25
3.2%
23 Mar 2021
Salter-Cid Luisa Chief Scientific Officer
Sold, plan not stated
$52.05K 5,491 at 9.48
2.6%
23 Mar 2021
Christian Waage EVP & General Counsel
Sold, plan not stated
$52.05K 5,490 at 9.48
0.9%
23 Mar 2021
Giraudo Bryan Chief Financial Officer
Sold, plan not stated
$52.05K 5,490 at 9.48
4.8%
30 Dec 2019
Dupont Jakob Chief Medical Officer
Sold, plan not stated
$600.00K 40,000 at 15.00
100%
Sold half or more
27 Dec 2019
Dupont Jakob Chief Medical Officer
Sold, plan not stated
$31.53K 1,994 at 15.81
100%
Sold half or more
20 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$4.03M 183,607 at 21.96
2.7%
18 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$997.64K 45,600 at 21.88
0.7%
17 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$505.79K 23,400 at 21.62
0.3%
16 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$284.33K 13,213 at 21.52
0.2%
11 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$1.71M 80,403 at 21.31
1.2%
10 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$679.87K 32,373 at 21.00
0.5%
6 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$187.10K 8,700 at 21.51
0.1%
5 Sep 2019
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$274.43K 12,704 at 21.60
0.2%
29 Aug 2019
Salter-Cid Luisa Chief Scientific Officer
Sold, plan not stated
$527.32K 26,252 at 20.09
17.5%
28 Aug 2019
Salter-Cid Luisa Chief Scientific Officer
Sold, plan not stated
$466.72K 23,748 at 19.65
13.6%
Showing 1–40 of 40.